Cidara Therapeutics (CDTX) Stock Chart & Stock Price History $22.36 -0.64 (-2.78%) Closing price 04:00 PM EasternExtended Trading$22.34 -0.02 (-0.09%) As of 04:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSustainabilityTrends Cidara Therapeutics Stock Price Performance 5 Day Performance-5.49%1 Month Performance-4.16%3 Month Performance-2.27%6 Month Performance+87.27%Year-To-Date Performance-16.82%1 Year Performance+68.12% Receive CDTX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Cidara Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address Remove Ads CDTX Stock Chart for Thursday, March, 13, 2025 CDTX Chart by TradingViewRemove Ads Cidara Therapeutics Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization03/12/2025$21.00$23.00+9.52%$23.66$21.00148,656 shs$162.08 million03/11/2025$22.39$21.00-6.21%$21.96$20.15126,939 shs$147.99 million03/10/2025$23.66$22.39-5.37%$24.14$21.78106,453 shs$157.78 million03/07/2025$23.61$23.66+0.21%$23.94$21.8552,851 shs$166.73 million03/06/2025$23.50$23.61+0.47%$24.00$23.1151,232 shs$166.38 million03/05/2025$23.16$23.50+1.47%$23.64$22.6251,437 shs$165.60 million03/04/2025$23.05$23.16+0.48%$24.00$22.2898,042 shs$163.21 million03/03/2025$24.90$23.05-7.43%$25.78$23.02150,161 shs$162.43 million02/28/2025$23.85$24.90+4.40%$25.24$23.16257,214 shs$175.47 million02/27/2025$22.13$23.85+7.77%$24.14$21.8261,265 shs$168.07 million Get the Latest News and Ratings for CDTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Cidara Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 02/26/2025$21.42$22.13+3.31%$22.59$21.42102,609 shs$155.95 million02/25/2025$20.50$21.42+4.49%$22.16$20.11105,739 shs$150.95 million02/24/2025$21.47$20.50-4.52%$21.52$19.9671,067 shs$144.46 million02/21/2025$22.38$21.47-4.07%$22.30$21.2351,838 shs$151.36 million02/20/2025$23.81$22.38-6.01%$23.40$20.5084,259 shs$157.78 million02/19/2025$24.00$23.81-0.79%$24.95$23.40168,700 shs$167.86 million02/18/2025$23.94$24.00+0.25%$24.32$23.6086,507 shs$169.20 million02/17/2025$23.94$23.94$24.30$22.34106,444 shs$168.78 million02/14/2025$23.33$23.94+2.61%$24.30$22.34106,444 shs$168.78 million02/13/2025$23.47$23.33-0.60%$24.99$22.80126,608 shs$164.48 million02/12/2025$21.99$23.47+6.73%$24.81$21.74125,686 shs$165.46 million Related Companies Nuvation Bio Stock Chart LENZ Therapeutics Stock Chart ChromaDex Stock Chart KalVista Pharmaceuticals Stock Chart Arbutus Biopharma Stock Chart Kura Oncology Stock Chart GH Research Stock Chart VectivBio Stock Chart Sana Biotechnology Stock Chart Valneva Stock Chart Receive CDTX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Cidara Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:CDTX) was last updated on 3/13/2025 by MarketBeat.com Staff From Our PartnersElon Musk Wants to Audit Fort Knox—What It Means for Your RetirementYou can take advantage of the coming tariff-fueled gold melt-up right inside your IRA or 401(k) – 100% TAX-FRE...Colonial Metals | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredYour Wealth is Under AttackHave you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's...American Alternative | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredAlert: DOGE goes liveElon will most likely be at the helm of it all. And just days from now, could bring about the biggest econo...Altimetry | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredTrump doesn’t give a damnPorter Stansberry: “I met with Trump’s biggest backers… they’re scooping up these 10 stocks” I recently met...Porter & Company | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cidara Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cidara Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
